Cannabis study suggests women may need less THC to get to the same effects as men
Women tend to experienced the same acute effects of cannabis as men at a lower dose of THC, according to new research published in Psychopharmacology which sought to mimic real-world smoking practices.
Australian Government Improves Medical Cannabis Export Legislation
Australia’s Export Control Amendment (Certificate of Narcotics Exports) Bill 2020 is to improve access to global markets for the nation’s medicinal cannabis and hemp industries.
The new bill, which passed the Senate last Wednesday, broadens current legislation certifying agricultural exports to allow for certification of legitimate exports of narcotic products, including medical cannabis and low-THC hemp.
Cannabis Drinks Are Projected To Make $2 Billion This Year
According to a report by Prohibition Partners, the global cannabis drinks market will be worth $1.82 billion by the end of the year. That number is driven by consumers looking for cost-friendly relief from the current COVID-19 pandemic.
COVID Spikes a Tsunami of Cannabis Sales
COVID-19 has devastated most businesses but created a surge in cannabis sales—a trend that's likely to continue. Strange bedfellows, COVID-19 and cannabis. As the pandemic wreaked havoc on the U.S. and global economies, cannabis sales rocketed higher across multiple markets in North America. California cannabis sales soared nearly 160% compared to the same day in March 2019, while sales in Washington rocketed 100% and Colorado saw a 46% increase on the same day. This surge doesn't appear to be a flash in the pan either.
Curaleaf amends deal to acquire cannabis multistate operator Grassroots
Vertically integrated cannabis company Curaleaf Holdings revised its deal to acquire privately owned multistate operator Grassroots Cannabis:
- Eliminates the $75 million cash component of the original agreement.
- Increases the Curaleaf share consideration from $40 million to $90.1 million.
The share consideration for the deal will now total about 118.9 million Curaleaf subordinate voting shares.
Martha Stewart's CBD For Pets Brand Expected To Hit Markets This Fall
Martha Stewart, the 78-year-old entrepreneur is now working with Canadian company Canopy Growth to develop a line of CBD products for pets.
That partnership is expected to bear fruit by September when Canopy Growth plans to launch a line of CBD products for pets designed with Stewart as a consultant. The project with Stewart is part of a wave of new products from Canopy Growth, including a host of cannabis-infused beverages such as Tweed Houndstooth & Soda and Tweed Bakerstreet & Ginger.
Emerald Health Therapeutics’ Verdélite Launches Souvenir™ Cannabis Brand in Québec
Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announces that its Verdélite Sciences subsidiary in St. Eustache, Québec, has launched its new Souvenir cannabis brand in the province. The Souvenir product line initially consists of select dried flower products from two Emerald cultivars, Grapefruit GG4 and Chemdog. The first shipments have been made to the SQDC, Québec’s cannabis distribution board, and will be distributed through SQDC retail and online stores.
CBD OF DENVER, INC. (CBDD) Acquires Swiss Cannabis Wholesale Operations
CBD of Denver, Inc. (OTC: CBDD), a full-line CBD and Hemp oil company ("CBDD") selling Black Pearl CBD and hemp products and the owner of CBD Social Network, is pleased to announce that CBDD has acquired Rockflowr GmbH, a Swiss cannabis wholesale operation.
Kalacan Hellas Receives Greek License to Produce and Commercialize Medical Cannabis in Europe
Kalacan Hellas S.A. (“Kalacan” or the “Company”) (Privately Held) is pleased to announce that it has received its medical cannabis installation license (the “License”). The License, one of the largest issued by the Greek government, authorizes Kalacan to establish cultivation, processing and manufacturing facilities, as well as conduct Licensed Activities, including import and export of cannabis. Securing an EU-based license provides Kalacan with a first-mover production and distribution platform in the developing European cannabis market.
WeedMD Launches Cannabis 2.0 Product Line of Medical Vaporizers
WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce the launch of its innovative line of strain-specific medicinal vaporizer pens (vapes). The ‘Aurum’ vapes are available to Starseed patients across Canada as part of the Company’s expanding medical cannabis product portfolio as an insured benefit. WeedMD’s medical vaporization product line will be available to medical patients in the coming weeks and will expand into the adult-use market under its Color Cannabis brand in Q3, 2020.
Israel Takes Step Toward Cannabis Legalization
Israel is a step closer toward cannabis legalization, as the Ministerial Committee for Legislation approved a bill to legalize cannabis use on Sunday.
The legislation is poised to legitimatize the possession of up to 50 grams of marijuana. In addition, it also allows individuals older than 21 to possesses and consume up to 15 grams of marijuana.
Croatia May Be Trying to Legalize Recreational Cannabis
Like many EU countries, Croatia has been slowly changing its laws to allow for greater legal (or at least decriminalized) cannabis use.
However, earlier this year, some in Croatia’s government got a bit impatient, attempting to jump steps in order to legalize recreational cannabis.